Non-steroidal Anti-inflammatory Drug (NSAID)-, Potassium Supplement-, Bisphosphonate-, and Doxycycline-Mediated Peptic Ulcer Effects: A Narrative Review
- PMID: 38333496
- PMCID: PMC10849936
- DOI: 10.7759/cureus.51894
Non-steroidal Anti-inflammatory Drug (NSAID)-, Potassium Supplement-, Bisphosphonate-, and Doxycycline-Mediated Peptic Ulcer Effects: A Narrative Review
Abstract
Peptic ulcers are a common condition that arises from an imbalance between acid production and gastroduodenal protective factors. Various drugs, including non-steroidal anti-inflammatory drugs (NSAIDs), potassium supplements, bisphosphonates, and doxycycline, can increase the development of peptic ulcers. NSAIDs are one of the most common medications prescribed for pain relief, and they also inhibit the formation of cyclooxygenase-1 (COX-1). COX-1 helps in the production of mucus that lines the stomach, so by inhibiting COX-1, NSAIDs reduce the mucus produced by the stomach and increase the likelihood of gastric ulcer formation. Additionally, NSAIDs are acidic, and increasing the amount of any acid in the stomach can result in promoting ulcer development. Potassium supplements are used to reduce the effects of hypertension, decrease the development of kidney stones, and treat hypokalemia. The various types of transporters and channels used to move potassium across cell membranes increase hydrogen being pumped, increasing gastric acid production and ulcer formation. Bisphosphonates are used to treat a variety of skeletal disorders that require inhibition of osteoclast activity. Nitric oxide (NO) has been shown to have a therapeutic effect on gastric ulcers, and some bisphosphonates have been shown to decrease the production of nitric oxide, resulting in increased damage to the gastric mucosa. Finally, doxycycline is a broad-spectrum tetracycline antibiotic that is typically used to treat anthrax poisoning, skin lesions, and sexually transmitted diseases. A harmful adverse effect of doxycycline is the formation of peptic and gastric ulcers related to the drug being highly acidic once it has dissolved.
Keywords: bisphosphonates; doxycycline; non-steroidal anti-inflammatory drugs (nsaids); peptic ulcers; potassium.
Copyright © 2024, Keller et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.Scand J Gastroenterol Suppl. 1996;220:124-7. doi: 10.3109/00365529609094763. Scand J Gastroenterol Suppl. 1996. PMID: 8898449 Review.
-
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28056333 Chinese.
-
Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs.Am J Med. 1998 Mar 30;104(3A):43S-51S; discussion 79S-80S. doi: 10.1016/s0002-9343(97)00211-8. Am J Med. 1998. PMID: 9572320 Review.
-
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.Dig Liver Dis. 2000 Oct;32(7):583-94. doi: 10.1016/s1590-8658(00)80840-3. Dig Liver Dis. 2000. PMID: 11142556
-
Non-steroidal anti-inflammatory drug-induced gastroduodenal injury: therapeutic recommendations.Aliment Pharmacol Ther. 1991;5 Suppl 1:99-109. doi: 10.1111/j.1365-2036.1991.tb00753.x. Aliment Pharmacol Ther. 1991. PMID: 1679675 Review.
Cited by
-
Gastroprotective and Antioxidant Effects of Ferula Plant Extract Against Indomethacin Induced Gastric Ulcer in Rats.Food Sci Nutr. 2025 Jul 30;13(8):e70730. doi: 10.1002/fsn3.70730. eCollection 2025 Aug. Food Sci Nutr. 2025. PMID: 40746654 Free PMC article.
-
Deciphering the Effect of Hyaluronic Acid/Collagen Hydrogel for Pain Relief and Tissue Hydration in a Rat Model of Intervertebral Disc Degeneration.Polymers (Basel). 2024 Sep 11;16(18):2574. doi: 10.3390/polym16182574. Polymers (Basel). 2024. PMID: 39339037 Free PMC article.
References
-
- Epidemiology of peptic ulcer disease. Kurata JH, Haile BM. https://pubmed.ncbi.nlm.nih.gov/6378441/ Clin Gastroenterol. 1984;13:289–307. - PubMed
-
- Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Digestion. 2011;84:102–113. - PubMed
-
- The incidence of duodenal and gastric ulcers in a large health maintenance organization. [ Sep; 2023 ];Kurata JH, Honda GD, Frankl H. https://ajph.aphapublications.org/doi/epdf/10.2105/AJPH.75.6.625. Am J Public Health. 1985 75:625–629. - PMC - PubMed
-
- Peptic ulcer disease. Lanas A, Chan FK. Lancet. 2017;5:613–624. - PubMed
-
- Risk factors of perioperative mortality from complicated peptic ulcer disease in Africa: systematic review and meta-analysis. Peiffer S, Pelton M, Keeney L, et al. https://bmjopengastro.bmj.com/content/7/1/e000350 BMJ Open Gastroenterol. 20201;7:0. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources